Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in tissue-targeted AAV gene therapy, today announces the publication of a seminal resear ...

Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational ...

PHILADELPHIA, PA — Latus Bio, Inc. has unveiled groundbreaking research on a novel adeno-associated virus (AAV) capsid variant, AAV-Ep+, which shows significant promise for advancing gene ...

Jack Latus, CEO of Latus Group and a former professional rugby player for Hull KR and Harlequins. Jack is one of the youngest founders and CEOs in the occupational health sector and has built ...

PHILADELPHIA, April 29, 2025--Latus Bio Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced upcoming oral and poster presentations at the American Society ...

Typhlodromalus peregrinus consumed P. latus eggs, immatures and adults. T. peregrinus consumed 23-75% of the prey population in 6 days. T. peregrinus did not reject P. oleivora as prey, but favored P.

With its novel adeno-associated virus discovery platform, Latus Bio is addressing problems associated with high-dose gene therapy for central nervous system diseases, aiming to usher in a new era ...

NorthEdge has invested in Latus Group, an occupational health service provider. Hull, UK-based Latus provides a range of services across occupational health, health surveillance, testing and ...

Ellen E. Latus, 77, of Whitesboro passed away peacefully, surrounded by the love of her family at her son’s home in Marcy, on Friday October 13, 2023. She was born on September 15, 1946 in Utica ...

Latus Health’s flexible approach ensures your employees get the wellbeing support they need. The Hull-based company are on hand to help take care of all your employee wellbeing and occupational ...

Latus continues to advance its pipeline of novel AAV capsid variants that target disease-relevant cell types in other regions of the central nervous system (e.g., cortex, cerebellum, spinal cord ...

PHILADELPHIA, May 14, 2025--Latus Bio, Inc. (Latus), a biotechnology company pioneering advances in AAV gene therapy, has announced new research published today in Science Translational Medicine ...